Page 8 - Indian Pharma Companies

Cold wave across US to bring big business for Indian drug companies

There have been 20.4 million to 23.6 million flu illnesses in the US between October 1, 2018, and February 23, 2019

Indian pharma to hit double-digit growth on US sales, weak rupee: CRISIL

As per Crisil, green shoots are already visible in the first quarter for 20 of these listed drug-makers

Warning letters to Indian pharma companies from US FDA declining: Study

The number of cases of data integrity violations too is showing a decline, says study by IPA and consultancy firm McKinsey

Indian pharma sees traction in novel biologics

While Glenmark is betting on its biologic for atorpic dermatitis, Biocon was the first to develop and introduce two novel biologics in the Indian market

Competition takes shine off niche pharma products

Aurobindo has been able to partially buck the trend; analysts expect prospects of most players to improve in second half of FY19